1999 Press Releases
Frequently asked questions concerning the NCCAM and National Cancer Institute co-sponsored clinical trial involving patients with pancreatic cancer.
The Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) has announced awards, in collaboration with the NCCAM, to establish the first Dietary Supplements Research Centers with an emphasis on botanicals. The Research Centers are expected to greatly advance the scientific base of knowledge about botanicals, including issues of their safety, effectiveness, and biological action.
DHHS Secretary Donna E. Shalala today announced the appointment of Stephen E. Straus, M.D., as the director for the NCCAM at the NIH.
A multicenter study to test the efficacy of Ginkgo biloba (botanical product) on older individuals who are at risk for dementia (cognitive decline in memory) has been awarded by the NCCAM in collaboration with the National Institute on Aging (NIA).
The NCCAM recently awarded five Specialized Center Research Grants to further complementary and alternative medicine (CAM) research in the following areas: aging, arthritis, craniofacial disorders, neurological disorders, women’s health, and cardiovascular disease in African Americans.
The first U.S. multicenter study to investigate the dietary supplements glucosamine and chondroitin sulfate for knee osteoarthritis has been awarded by the NCCAM in collaboration with the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Includes a Q&A Factsheet on Glucosamine/Chondroitin Sulfate for Knee Osteoarthritis attachment.
DHHS Secretary E. Shalala today announced the appointment of 17 members to the new National Advisory Council for Complementary and Alternative Medicine. The council will provide advice to the director of the National Center for Complementary and Alternative Medicine at the National Institutes of Health in carrying out the new Center’s congressional mandate, core programs, and activities.
A federally chartered Cancer Advisory Panel on Complementary and Alternative Medicine (CAPCAM) has been established to provide advice and recommendations in the evaluation of complementary and alternative (CAM) therapies for cancer treatment and prevention.